NANOVIRICIDES, INC. Quarterly Interest Expense in USD from Q3 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Nanoviricides, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2012 to Q4 2023.
  • Nanoviricides, Inc. Interest Expense for the quarter ending December 31, 2023 was $13.3K.
  • Nanoviricides, Inc. annual Interest Expense for 2023 was $938.000, a 81.7% decline from 2022.
  • Nanoviricides, Inc. annual Interest Expense for 2022 was $5.12K, a 94% decline from 2021.
  • Nanoviricides, Inc. annual Interest Expense for 2021 was $85.4K, a 8.82% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $13.3K +$13.2K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $36.5K +$35.6K +4224% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q4 2022 $2.54K $94.00* -$2.54K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $5.08K $844 -$47 -5.28% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $5.12K -$3.19K -$6.9K -186% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 $12K $4.79K +$4.29K +867% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $7.73K $2.63K -$34.7K -92.9% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $42.4K $891 -$43K -98% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $85.4K $3.71K -$40.9K -91.7% Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 $126K $495 -$44.4K -98.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $171K $37.3K +$33.2K +803% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $138K $43.9K +$43.9K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $93.7K $44.6K +$44.6K Apr 1, 2020 Jun 30, 2020 10-K 2021-10-12
Q1 2020 $49.1K $44.9K +$44.9K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $4.13K $4.13K +$4.13K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $0 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $0 $0 Apr 1, 2019 Jun 30, 2019 10-K 2021-10-12
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-22
Q4 2018 $0 Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $0 -$125K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q3 2017 $661K $125K -$120K -49% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $781K $125K -$126K -50.3% Apr 1, 2017 Jun 30, 2017 10-K 2017-09-28
Q1 2017 $907K $166K -$135K -44.9% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $1.04M $245K $0 0% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-14
Q3 2016 $1.04M $245K $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.04M $251K +$14.5K +6.11% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 $1.03M $301K -$1.62M -84.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $2.65M $245K -$2.44K -0.99% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $2.65M $245K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $2.65M $237K +$117K +96.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 $2.53M $1.92M -$805K -29.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $3.34M $247K +$122K +97.1% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $3.22M $245K +$124K +103% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $3.09M $120K Apr 1, 2014 Jun 30, 2014 10-K 2016-09-16
Q1 2014 $2.73M +$1.9M +231% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $126K Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-25
Q3 2013 $121K +$121K Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-02-23
Q1 2013 $822K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.